Evogene Ltd. EVGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | 60.38% | -1,343.33% | 17.66% | 33.03% | |
| Total Depreciation and Amortization | -46.12% | -40.36% | -25.76% | -53.80% | |
| Total Amortization of Deferred Charges | -100.00% | 0.00% | -- | -- | |
| Total Other Non-Cash Items | -179.23% | 142.08% | 188.89% | -263.98% | |
| Change in Net Operating Assets | -93.06% | 41.01% | 295.24% | 17.68% | |
| Cash from Operations | 14.21% | 41.11% | 57.82% | -26.08% | |
| Capital Expenditure | -350.00% | 98.14% | 92.31% | 14.18% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 559.98% | 12.58% | -130.50% | 45.07% | |
| Cash from Investing | 567.14% | 17.18% | -130.81% | 43.95% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 15.60% | 57.10% | 53.62% | 36.80% | |
| Issuance of Common Stock | -81.20% | -- | 5,060.24% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -10,096.00% | -218.27% | -2,600.00% | 90.65% | |
| Cash from Financing | -144.25% | -24.27% | 2,847.68% | 56.68% | |
| Foreign Exchange rate Adjustments | -111.11% | 228.57% | 228.57% | -11.11% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -3.48% | 83.99% | 134.31% | 11.87% | |